ECYT..$3.54 Catalysts upcoming: Two investment conference in Feb. Citibank on 27th & RBC Capital on 28th.
NEAR-TERM CATALYSTS
3/1 Endocyte (ECYT) Earnings Q4:11 results and update on path forward in the EU and other programs
3/24-3/27 Endocyte (ECYT) Clinical Data Potential presentation of updated PFS and overall survival Data from the randomized PII study of EC145 in the platinum resistant ovarian cancer setting Society for Gynecologic Oncology; Austin, TX
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.